CRISPR Therapeutics Logo

CRISPR Therapeutics

🇨🇭
CRSP
CH0334081137

CRISPR Therapeutics is a leading biotechnology company based in Switzerland, specializing in the development of breakthrough gene-editing therapies. By leveraging CRISPR/Cas9 technology, the company addresses serious human diseases through the creation of innovative cell-based therapeutic candidates.

Next Quarterly Earnings

Monday, August 10, 2026
CW 33
After-Hours
In 29 days

After-hours — after the market close (typically after 5:30 p.m. CET).

Quiet period starts on July 13, 2026

Stock Price

Frequently asked questions

When will CRISPR Therapeutics report its next quarterly earnings?

CRISPR Therapeutics is scheduled to report its next quarterly earnings on 08/10/2026. After-hours — after the market close (typically after 5:30 p.m. CET).

When did CRISPR Therapeutics last report quarterly earnings?

CRISPR Therapeutics last reported quarterly earnings on 5/4/2026 (Q2 2026). Earnings per share (EPS) came in at -1.28 USD.

How do I add the CRISPR Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.20
Actual:
Q2 2026
Missed
Estimate:-$1.22
Actual:-$1.28
Difference:-$0.06
Q1 2026
Missed
Estimate:-$1.16
Actual:-$1.37
Difference:-$0.21

Company Information

Name
CRISPR Therapeutics
Ticker Symbol
CRSP
ISIN
CH0334081137
Country
🇨🇭
Switzerland
Sector
Technology